InvestorsHub Logo
Followers 0
Posts 14
Boards Moderated 0
Alias Born 11/30/2023

Re: None

Saturday, 12/02/2023 1:15:45 PM

Saturday, December 02, 2023 1:15:45 PM

Post# of 36
Cue Health should take Sherlock Biosciences' playbook with its acquition of Sense Biodection's "Veros", an instrument-free rapid molecular test platform with results comparable to qRT-PCR lab results, that would accelerated reaching the global consumers. And there’s been a lot of speculation that 2023 will see increased M&A activity in the life sciences industry; maybe Cue Health will lead this trend in the private market?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HLTH News